Disease Area Assessment

Disease Area Assessment

We leverage our deep domain knowledge and significant experience to provide support to marketing teams of global Bio-pharma companies on diseases/therapy areas to assess epidemiology, competitive and market landscapes, standard of care, market access and pricing, market segmentation analysis, launch uptake of products.

The formulation of a disease area strategy is done to determine the potential risk and return that the therapeutic area will bring to the company. The assessment intends to select a disease that is likely to optimize a company’s investment on new therapeutic areas. Disease area strategy assessment takes into consideration a series of properties to evaluate the commercial opportunity. These include convenience, cost and safeness of the disease to be selected.

Disease area strategy assessment allows an organization to increase their drug platform healthcare services by having an R&D focus on the discovery of effective drugs for disease areas of high medical need that can bring value into the company. The disease area strategy also takes into consideration the reimbursement potential for the company, which implies the study of the regulatory framework to analyze how flexible are the policies related to the disease area.

We share our clients' ambitions. We work to understand their reality and deliver true results—focusing on strategic decisions and practical actions. And we align our incentives with our clients' objectives, so they know we're in it together.

How can we help you?

To discuss how our team can help your business achieve true results, please

Contact Us